Zenda Technologies

Biotechnology, Health Care, Medical Device
Founded in 2007-01-01
Roswell, Georgia, United States
For Profit

About Zenda Technologies

Zenda has a patent pending technology that for the first time makes it practical for your primary care physician to include a 7-10 minute scan for the earliest cognitive change signs of dementia including Alzheimer’s Disease - starting at age 50. All too often cognitve problems such as Alzheimer’s disease are diagnosed late in the disease cycle. Zenda’s DETECT test enables physicians to diagnose early when drug therapies and even life style changes are the most effective. Zenda has completed several clinical studies; including the latest with 400 patients and the results are excellent. These studies show that the DETECT test on the IMTech immersive neuropsychological testing platform is as accurate in 10 minutes as the gold standard 90 minute test.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 3000000 USD
  • Last Funding: 3000000 USD (Seed)
  • Funding Status: Seed

Technology Stack

Zenda Technologies actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Medical Device

Headquarters: Roswell, Georgia, United States